Hospital De Base de São José do Rio Preto - CIP São José

Hospital De Base de São José do Rio Preto - CIP São José
São José Do Rio Preto, São Paulo, 15090-000
Select an option

Our team

Medical staff
Daniele Frassato
Raissa Mendes
Mariana Martins
Juliane Garcia
Ana Affonso
Juliana Vieira
João Daniel Cardoso Guedes

Open studies

Breast Cancer
A Study of Imlunestrant Versus Standard Endocrine Therapy in Participants With Early Breast Cancer - EMBER-4 - Eli Lilly and CompanySee more
A Study Evaluating the Efficacy and Safety of Inavolisib Plus Fulvestrant Compared With Alpelisib Plus Fulvestrant in Participants With HR-Positive, HER2-Negative, PIK3CA Mutated, Locally Advanced or Metastatic Breast Cancer Post CDK4/6i and Endocrine Combination Therapy - INAVO121 - Hoffmann-La RocheSee more
Cardiac arrhythmia
A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation - LIBREXIA-AF - Janssen Research & Development, LLCSee more
Cervical cancer
Nivolumab-ipilimumab and Chemoradiation for Cervical Cancer - Hospital Israelita Albert EinsteinSee more
Head and neck cancer
NBTXR3 With or Without Cetuximab in LA-HNSCC - NanobiotixSee more
Heart failure
A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and Inflammation - HERMES - Novo Nordisk A/SSee more
Inflammation
A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and Inflammation - HERMES - Novo Nordisk A/SSee more
Leukemia
PK, PD, Safety and Immunogenicity of Spectrila in Adults with Acute B-cell Lymphoblastic Leukaemia - Syneos HealthSee more
Lupus
A Study to Assess Effectiveness and Safety of Deucravacitinib Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (SLE) - POETYK SLE-1 - Bristol-Myers SquibbSee more
Multiple myeloma
A Study Comparing Talquetamab Plus Pomalidomide, Talquetamab Plus Teclistamab, and Elotuzumab, Pomalidomide, and Dexamethasone or Pomalidomide, Bortezomib, and Dexamethasone in Participants With Relapsed or Refractory Myeloma Who Have Received an Anti-CD38 Antibody and Lenalidomide - MonumenTAL-6 - Janssen Research & Development, LLCSee more
Pneumonia
Efficacy and Safety of Trimodulin (BT588) in Subjects with Severe Community-acquired Pneumonia (sCAP) - ESsCAPE - BiotestSee more
LinkedinInstagramFacebook
Terms and ConditionsPrivacy Policy